Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Bartsch

Showing results (91-100 of 228) with videos related to

Pageof 23
Sort By:
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 19, 2010
Vienna international summer school on experimental and clinical oncology for medical students: an Austrian cancer education projectSabine Fromm-Haidenberger, Gudrun Pohl, Joachim Widder, et al.
Anticancer Research|January 10, 2014
Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysisSimon Peter Gampenrieder, Franz Romeder, Claudia Muß, et al.
BMC Cancer|October 27, 2022
Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in AustriaChristine Deutschmann, Rupert Bartsch, Christian F Singer, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2005
Oral vinorelbine alone or in combination with trastuzumab in advanced breast cancer: results from a pilot trialRupert Bartsch, Catharina Wenzel, Ursula Pluschnig, et al.
Breast (Edinburgh, Scotland)|May 20, 2008
Factors influencing the time to development of brain metastases in breast cancerSabine Fromm, Rupert Bartsch, Margaretha Rudas, et al.
Wiener Klinische Wochenschrift|January 28, 2022
Updated Austrian treatment algorithm in HER2+ metastatic breast cancerRupert Bartsch, Simon Peter Gampenrieder, Gabriel Rinnerthaler, et al.
Anti-Cancer Drugs|June 3, 2005
Darbepoetin alpha as treatment for anemia in patients receiving chemotherapy: a single-center experienceRupert Bartsch, Catharina Wenzel, Ursula Sevelda, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 1, 2014
Outcome of chemotherapy extravasation in a large patient series using a standardised management protocolUrsula Pluschnig, Werner Haslik, Günther Bayer, et al.
BMC Clinical Pharmacology|July 21, 2007
Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxelRupert Bartsch, Guenther G Steger, Birgit Forstner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2007
Capecitabine and trastuzumab in heavily pretreated metastatic breast cancerRupert Bartsch, Catharina Wenzel, Gabriela Altorjai, et al.
Pageof 23

Showing results (91-100 of 228) with videos related to

Sort By:
Pageof 23
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 19, 2010
Vienna international summer school on experimental and clinical oncology for medical students: an Austrian cancer education projectSabine Fromm-Haidenberger, Gudrun Pohl, Joachim Widder, et al.
Anticancer Research|January 10, 2014
Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysisSimon Peter Gampenrieder, Franz Romeder, Claudia Muß, et al.
BMC Cancer|October 27, 2022
Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in AustriaChristine Deutschmann, Rupert Bartsch, Christian F Singer, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2005
Oral vinorelbine alone or in combination with trastuzumab in advanced breast cancer: results from a pilot trialRupert Bartsch, Catharina Wenzel, Ursula Pluschnig, et al.
Breast (Edinburgh, Scotland)|May 20, 2008
Factors influencing the time to development of brain metastases in breast cancerSabine Fromm, Rupert Bartsch, Margaretha Rudas, et al.
Wiener Klinische Wochenschrift|January 28, 2022
Updated Austrian treatment algorithm in HER2+ metastatic breast cancerRupert Bartsch, Simon Peter Gampenrieder, Gabriel Rinnerthaler, et al.
Anti-Cancer Drugs|June 3, 2005
Darbepoetin alpha as treatment for anemia in patients receiving chemotherapy: a single-center experienceRupert Bartsch, Catharina Wenzel, Ursula Sevelda, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 1, 2014
Outcome of chemotherapy extravasation in a large patient series using a standardised management protocolUrsula Pluschnig, Werner Haslik, Günther Bayer, et al.
BMC Clinical Pharmacology|July 21, 2007
Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxelRupert Bartsch, Guenther G Steger, Birgit Forstner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2007
Capecitabine and trastuzumab in heavily pretreated metastatic breast cancerRupert Bartsch, Catharina Wenzel, Gabriela Altorjai, et al.
Pageof 23